Treprostinil Inhalation Powder (MannKind Corp)

N/A

Report date: 2025/08/29 20:01:31

Base Information

Drug NameTreprostinil Inhalation Powder (MannKind Corp)
Drug Alias NameTreTTyvaso Dpi
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid IP receptor agonists
TargetsProstanoid IP receptor
Therapy Area/IndicationsLung Diseases, InterstitialPulmonary Arterial HypertensionHypertension, Pulmonary
Global Approved IndicationsLung Diseases, InterstitialPulmonary Arterial HypertensionHypertension, Pulmonary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2022/05/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMannKind Corp
China Registration ClassN/A

Develop Information

Active CompaniesUnited Therapeutics Corp
Inactive CompaniesMannKind Corp
Active IndicationsLung Diseases, InterstitialPulmonary Arterial HypertensionHypertension, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A